Ten Versus Fifteen Centimeter Pouch in IPAA Surgery (TESTIMONY)
Ileal Reservoir Length and Functional Outcome in Ileal Pouch-anal Anastomosis
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
The primary aim of this randomized controlled trial is to compare functional outcome in terms of bowel function correlated with quality of life for patients who undergo primary ileal pouch-anal anastomosis surgery with an ileal (J-shaped) reservoir length of either 10 cm or 15 cm.
Secondary aims include health-related quality of life measures and postoperative complications.
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Anders Mark-Christensen, MD, PhD
- Phone Number: +45 51236691
- Email: anders.mark.christensen2@rsyd.dk
Study Locations
-
-
-
Aarhus, Denmark
- Recruiting
- Aarhus University Hospital
-
Contact:
- Sanne Harsløf, MD PhD
- Email: sanne.harslof@rm.dk
-
Hvidovre, Denmark
- Recruiting
- Hvidovre Hospital
-
Contact:
- Frederik Rønne Pachler, MD PhD
- Email: fpachler@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Undergoing ileal pouch-anal anastomosis (IPAA) for ulcerative colitis or familial adenomatous polyposis (FAP) (implying a normal sphincter function as judged by history and clinical examination)
- Signed informed consent
- Able to perform both a small (10 cm) and medium-size (15 cm) pouch with adequate reach and no tension as determined subjectively by the surgeon intraoperatively
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: 10 cm
Ileal reservoir length of 10 cm
|
A 10 cm pouch will be constructed
|
|
Active Comparator: 15 cm
Ileal reservoir length of 15 cm
|
A 15 cm pouch will be constructed
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pouch dysfunction score
Time Frame: 1, 3, 5 and 10 years after surgery
|
Ranges from 0 to 7.5, where a low score indicates good bowel function will little to no impact on quality of life
|
1, 3, 5 and 10 years after surgery
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Short Inflammatory Bowel Disease Questionnaire
Time Frame: 1, 3, 5 and 10 years after surgery
|
Consists of 10 questions with a total score range from 10 (poor health-related quality of life) to 70 (good health-related quality of life)
|
1, 3, 5 and 10 years after surgery
|
|
Short-form (SF)-36
Time Frame: 1, 3, 5 and 10 years after surgery
|
Consists of questions relating to 8 domains of life with a total score ranging from 0-100, with lower numbers indicating worse health status
|
1, 3, 5 and 10 years after surgery
|
|
Postoperative complications using the Comprehensive Complication Index (CCI)
Time Frame: 90 days after surgery
|
The CCI is a continuous scale, where each postoperative complication as defined by Clavien-Dindo is assigned a weigth based on its severity.
A total summarized score taking all complications into account is thus generated.
|
90 days after surgery
|
|
Pouch failure
Time Frame: 1, 3, 5 and 10 years after surgery
|
Hazard ratio of pouch failure defined as an intended permanent ileostomy with or without pouch excision
|
1, 3, 5 and 10 years after surgery
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Neoplasms by Site
- Neoplasms
- Genetic Diseases, Inborn
- Intestinal Diseases
- Neoplasms by Histologic Type
- Gastrointestinal Neoplasms
- Digestive System Neoplasms
- Digestive System Diseases
- Gastrointestinal Diseases
- Colorectal Neoplasms
- Intestinal Neoplasms
- Neoplasms, Glandular and Epithelial
- Colonic Diseases
- Adenoma
- Gastroenteritis
- Inflammatory Bowel Diseases
- Neoplastic Syndromes, Hereditary
- Adenomatous Polyps
- Intestinal Polyposis
- Colitis
- Colitis, Ulcerative
- Adenomatous Polyposis Coli
Other Study ID Numbers
Other Study ID Numbers
- OP_2227
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.